[The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B].
Petrovskaia
I A
IA
Kushko
L Ia
LIa
Fedorchenko
S V
SV
Vovk
A D
AD
Listopad
N K
NK
Antoniak
S N
SN
Drannik
G N
GN
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D006509:Hepatitis B / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology; D011994:Recombinant Proteins; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Vliianie rekombinantnogo al'fa-2-interferona (reaferona) na funktsional'nuiu aktivnost' estestvennykh killerov pri ostrom virusnom gepatite B.